Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. T...
Saved in:
Published in | Diabetes, metabolic syndrome and obesity Vol. 12; pp. 2405 - 2410 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.11.2019
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance.
The aim of the present study was to evaluate the possible association between HSI and complications in T1DM.
Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level.
Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications.
These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. |
---|---|
AbstractList | Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. Keywords: fatty liver, type 1 diabetes, diabetes complications Cesare Tripolino,1 Concetta Irace,2 Antonio Cutruzzolà,2 Martina Parise,1 Milena Barone,1 Caterina Scicchitano,1 Claudio Cortese,3 Agostino Gnasso1 1Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy; 2Department of Health Science, University Magna Graecia, Catanzaro, Italy; 3Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, ItalyCorrespondence: Agostino GnassoMetabolic Diseases Unit, Department of Clinical and Experimental Medicine, Mater Domini Hospital, Magna Græcia University, Catanzaro, ItalyTel +39 9613697039Fax +39 9613697250Email gnasso@unicz.itIntroduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance.Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM.Methods: Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level.Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications.Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.Keywords: fatty liver, type 1 diabetes, diabetes complications Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. INTRODUCTIONNon-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. AIMThe aim of the present study was to evaluate the possible association between HSI and complications in T1DM. METHODSMedical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. RESULTSOf the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. CONCLUSIONThese findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. |
Audience | Academic |
Author | Cutruzzolà, Antonio Gnasso, Agostino Cortese, Claudio Irace, Concetta Tripolino, Cesare Parise, Martina Scicchitano, Caterina Barone, Milena |
Author_xml | – sequence: 1 givenname: Cesare surname: Tripolino fullname: Tripolino, Cesare organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy – sequence: 2 givenname: Concetta orcidid: 0000-0001-5182-5473 surname: Irace fullname: Irace, Concetta organization: Department of Health Science, University Magna Graecia, Catanzaro, Italy – sequence: 3 givenname: Antonio surname: Cutruzzolà fullname: Cutruzzolà, Antonio organization: Department of Health Science, University Magna Graecia, Catanzaro, Italy – sequence: 4 givenname: Martina surname: Parise fullname: Parise, Martina organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy – sequence: 5 givenname: Milena surname: Barone fullname: Barone, Milena organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy – sequence: 6 givenname: Caterina surname: Scicchitano fullname: Scicchitano, Caterina organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy – sequence: 7 givenname: Claudio orcidid: 0000-0002-9429-5000 surname: Cortese fullname: Cortese, Claudio organization: Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy – sequence: 8 givenname: Agostino orcidid: 0000-0002-9220-9754 surname: Gnasso fullname: Gnasso, Agostino organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31819566$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1vEzEQhleoiJbSG2e0EhLiQILH689LpSgFEqmoh5Sz5fXOJo4267DeAP33eJtQEoR9sDV-5rVn_L7MztrQYpa9BjKmwOTHm6-Lu_GCUtBCP8suAKQaSULk2dH-PLuKcU2GIQmj9EV2XoACzYW4yGYz3Nreu3zRo-1D9DGftxX-yucxn8QYnLc9VvlP36_y-4ct5pDfeFtijzGfhs228S6lhza-yp7Xtol4dVgvs2-fP91PZ6Pbuy_z6eR25JgGPaqtIxygZsCptSgo11BQplDWFIVFICVnvBS2EJbowpUasSYgdamghAKKy2y-162CXZtt5ze2ezDBevMYCN3S2C4V1KABTpxTNUENgjGuS6YsE7IQRFS0VDRpXe-1trtyg5XDtu9scyJ6etL6lVmGH0YoyZmSSeD9QaAL33cYe7Px0WHT2BbDLhpa0IJJxenw7rf_oOuw69rUqoGSXDNQ-i-1tKkA39Yh3esGUTMRREmV_pkkavwfKs0KN94lh9Q-xU8S3h0lrNA2_SqGZvf4c6fghz3ouhBjh_VTM4CYwXFmcJw5OC7hb44b-AT_8VfxG3nPzfI |
CitedBy_id | crossref_primary_10_1177_03946320231223644 crossref_primary_10_3389_fmolb_2022_1019899 crossref_primary_10_1016_j_diabet_2023_101497 crossref_primary_10_3390_jcm10194466 crossref_primary_10_3390_antiox11112260 crossref_primary_10_3390_jpm13071148 crossref_primary_10_1021_acsptsci_3c00218 crossref_primary_10_23736_S2724_6507_20_03290_3 crossref_primary_10_1016_j_hbpd_2023_02_009 crossref_primary_10_1007_s40618_024_02333_2 crossref_primary_10_1155_2022_3150380 crossref_primary_10_1080_13880209_2021_1990969 crossref_primary_10_1136_bmjdrc_2020_001189 crossref_primary_10_1136_bmjopen_2023_073452 |
ContentType | Journal Article |
Copyright | 2019 Tripolino et al. COPYRIGHT 2019 Dove Medical Press Limited 2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 Tripolino et al. 2019 Tripolino et al. |
Copyright_xml | – notice: 2019 Tripolino et al. – notice: COPYRIGHT 2019 Dove Medical Press Limited – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 Tripolino et al. 2019 Tripolino et al. |
DBID | NPM AAYXX CITATION 3V. 7RV 7XB 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/DMSO.S221969 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) Research Library Research Library (Corporate) Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Public Health Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Research Library (Alumni Edition) Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Tripolino et al |
EISSN | 1178-7007 |
EndPage | 2410 |
ExternalDocumentID | oai_doaj_org_article_150cc8f0e9164459b48a4673606d2b82 A608789690 10_2147_DMSO_S221969 31819566 |
Genre | Journal Article |
GeographicLocations | Switzerland |
GeographicLocations_xml | – name: Switzerland |
GroupedDBID | --- 0YH 29F 2WC 53G 5VS 7RV 8C1 8FI 8FJ 8G5 ABUWG ACGFO ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 M~E NAPCQ NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TR2 UKHRP VDV AAYXX CITATION TDBHL 3V. 7XB 8FK MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c4919-fac0511f4152aae625913248e7f2e6ae10b545b6a36a093cb9eef0179b81b1313 |
IEDL.DBID | RPM |
ISSN | 1178-7007 |
IngestDate | Tue Oct 22 14:38:43 EDT 2024 Tue Sep 17 21:14:34 EDT 2024 Sat Aug 17 00:13:42 EDT 2024 Thu Oct 10 18:19:51 EDT 2024 Thu Feb 22 23:59:19 EST 2024 Wed Oct 25 09:34:00 EDT 2023 Tue Aug 20 22:11:13 EDT 2024 Thu Sep 26 18:39:19 EDT 2024 Sat Sep 28 08:44:06 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | type 1 diabetes fatty liver diabetes complications |
Language | English |
License | 2019 Tripolino et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4919-fac0511f4152aae625913248e7f2e6ae10b545b6a36a093cb9eef0179b81b1313 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5182-5473 0000-0002-9429-5000 0000-0002-9220-9754 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875487/ |
PMID | 31819566 |
PQID | 2327594189 |
PQPubID | 3933170 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_150cc8f0e9164459b48a4673606d2b82 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6875487 proquest_miscellaneous_2323478521 proquest_journals_2327594189 gale_infotracmisc_A608789690 gale_infotracacademiconefile_A608789690 gale_healthsolutions_A608789690 crossref_primary_10_2147_DMSO_S221969 pubmed_primary_31819566 |
PublicationCentury | 2000 |
PublicationDate | 20191101 |
PublicationDateYYYYMMDD | 2019-11-01 |
PublicationDate_xml | – month: 11 year: 2019 text: 20191101 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Diabetes, metabolic syndrome and obesity |
PublicationTitleAlternate | Diabetes Metab Syndr Obes |
PublicationYear | 2019 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
SSID | ssj0000070422 |
Score | 2.2933881 |
Snippet | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several... Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date,... INTRODUCTIONNon-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date,... Cesare Tripolino,1 Concetta Irace,2 Antonio Cutruzzolà,2 Martina Parise,1 Milena Barone,1 Caterina Scicchitano,1 Claudio Cortese,3 Agostino Gnasso1 1Metabolic... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2405 |
SubjectTerms | Atherosclerosis Biochemistry Body mass index Carotid arteries Complications and side effects Diabetes diabetes complications Diabetic retinopathy Electrocardiography Fatty liver Flow velocity Insulin Kidney diseases Laboratories Liver Liver diseases Medical records Original Research Regression analysis Tomography Triglycerides Type 1 diabetes Type 2 diabetes Ultrasonic imaging Variables Veins & arteries |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gL4ptAASOBOIXaju3Yx1KotkgLh1KpN8v2TkQvWUS2_5-ZOLtKxIELx8QTJZ7J2G-S52fG3unos49Z18kYVWtnoXbamdobyBsprYCRTbj-ZldX-uu1uZ5t9UWcsCIPXBx3goAlZ9cJQByjtfFJu6iJjCTsRiVXRl_hZ8VUAb4tiVuVnVVc3eJxYb3Ttjwnn9eX3z9eKkXSMIv5aJTt_3twns1OS-bkbCo6f8DuTxiSn5Znf8juQP-I3V1Pf8kfs9UKiCedOZF1d9vhZuAXJIrILwa-DwdsOH2C5VSHcsknYszAz-YU8yfs6vzLj7NVPe2YUGftpa-7mDHJZEezcoxAtQ1Wm9pB2ymwEaRIiJiSjY2Nwjc5eYCOcjIhepWNbJ6yo37bw3PGO9XkLMF4tQHdGh2bpFWXhepAqKibir3f-y38KsIYAQsK8m8g_4bJvxX7RE492JCc9XgCgxymIId_BblibygkoawNPSRlOLXCtQ7vIir2YbSgtMTI5DitLsDOkMDVwvJ4YYnplJfN-7CHKZ2HgLCzNV5Lh915e2imK4mi1sP2drRpdOsQDlXsWXlLDp3GgZPWZdqKtYv3Z-GVZUt_83MU-7ZYUGJR-eJ_uPElu4d4z5ellMfsaPf7Fl4hptql12P6_AG0_xij priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVkJcEO8GChgJxCk0dhzHPqG2tNoibUGUSr1ZjjOBXpLSbP8_nsQbNkLiGk-UeMbzsj_PALyTznjjvEyrohCp1ApTLXWRmgJ9zbnKcEATrs7U8kJ-uSwu44ZbH2GVG5s4GOq687RHvh88f1kYybX5dP07pa5RdLoaW2jchR0RMgWxgJ3D47Nv36ddFqpmI4UYEe_Ukmf_8-r868dzIagszMwXDSX7_zXMW55pjprcckMnD-FBjB_ZwSjwR3AH28dwbxVPyJ_AcomEkfaMgLrrrr_q2SkVRGSnPduIAmtG26-MclDGWQTF9OxoG17-FC5Ojn8cLdPYLSH10nCTNs4HBeMNeWTnkPKakGlKjWUjUDnkWRWipUq5XLnM5L4yiA3pYxUiV57z_Bks2q7FXWCNyL3nWBhRoywL6fJKisZnosFMOJkn8H7DN3s9FsWwIZkg_lrir438TeCQmDrRUCnr4UF389NGzbAhIvVeNxmGQFXKwlRSO0los0zVotIigTckEjveC50U0h6oTJc6fCVL4MNAQSoZJONdvFkQJkPFrWaUezPKoEp-PrwRu42q3Nu_Cy-Bt9MwvUnwtBa724Eml6UOoVACz8dVMk06GE26k6kSKGfrZ8aV-Uh79Wso9K1CMhkSyhf__62XcD9EcWa8ILkHi_XNLb4KkdK6eh3V4Q-yqRES priority: 102 providerName: ProQuest |
Title | Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31819566 https://www.proquest.com/docview/2327594189 https://search.proquest.com/docview/2323478521 https://pubmed.ncbi.nlm.nih.gov/PMC6875487 https://doaj.org/article/150cc8f0e9164459b48a4673606d2b82 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-tQ5r2MvFNxihGAvGUNnacxH7cykaH1DExJvXNsl0HKrF0Wrv_n7t8VI144yUP8UWJ7yP-nfO7C8BHabXX1svYZZmIpcpDrKTKYp0Fv-A8T0LNJpxd5dNb-W2ezfcg62phatK-d8tR9eduVC1_19zK-zs_7nhi4-vZJEeQjUB7PIABOuhOit5g3oL6WjUkd_oLz_jL7Ob76EYI6gRzCAfoxVQkl_dWorph_7-v5Z11qc-Z3FmELp7CUYse2WnzlM9gL1TP4WDWfh9_AdNpIIa0Z0TT3azWyzW7pHaI7HLNOkOEBaPNV0YZKOOspcSs2WSXXP4Sbi_Of06mcfuvhNhLzXVcWo_hxUtaj60NlNVgnilVKEoRcht44hArudymuU106p0OoaRodIhbecrTV7BfrarwBlgpUu95yLRYBImKtqmTovSJKEMirEwj-NTpzdw3LTEMphKkakOqNq2qIzgjpW5lqJF1fWL18Mu05jSIR71XZRIQpkqZaSeVlcQ1S_KFcEpE8J5MYpqq0G04mtM8UYXCuyQRfK4lKCDRMt62dQU4GWpt1ZM86UliIPn-cGd20wby2iDgLDItucLpfNgO05VETqvC6rGWSWWhEAhF8Lrxku2kO2eLoOj5T08r_RH0-rrNd-vlx_995Vs4RHinm8rJE9jfPDyGdwihNm4IAzXhQ3hydn51_WNYb0Tg8escz1Ew_QVJGx0H |
link.rule.ids | 230,315,730,783,787,867,888,2109,12237,21402,27938,27939,33280,33281,33758,33759,43593,43819,53806,53808,74350,74638 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BKwEXxGcbaKmRQJxCY8dx7BNqS6ssdBdEW6k3y3Gc0ktSmu3_x5N4w0aVuMYTJZ7xeGbs52eAD9woq4zlcZllLOZSuFhymcUqc7aiVCSuRxPOF6K44N8us8uw4NYFWOVqTuwn6qq1uEa-7yN_nilOpfpy8yfGW6NwdzVcofEQNpGqyo_qzcPjxc9f4yoLstlwxgbEO17Js_91fvbj8xljSAsziUU9Zf_9iXktMk1Rk2th6OQZPA35IzkYDP4cHrjmBTyahx3yl1AUDjHSliBQd9l21x2ZISEimXVkZQpXEVx-JViDEkoCKKYjR-vw8ldwcXJ8flTE4baE2HJFVVwb6x2M1hiRjXFY1_hKk0uX18wJ42hS-mypFCYVJlGpLZVzNfpj6TNXmtL0NWw0beO2gdQstZa6TLHK8TzjJi05q23Capcww9MIPq70pm8GUgztiwnUr0b96qDfCA5RqaMMUln3D9rbKx08Q_uM1FpZJ84nqpxnquTScESbJaJipWQR7KFJ9HAudHRIfSASmUv_lSSCT70EuqS3jDXhZIHvDJJbTSR3JpLeley0eWV2HVy50_8GXgTvx2Z8E-FpjWvvepmU59KnQhFsDaNk7LSfNPFMpoggn4yfiVamLc31757oW_hi0heUb_7_W3vwuDifn-rT2eL7W3jiMzo1HJbcgY3l7Z3b9VnTsnwXXOMv0T0UDA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgSBUXxDcphRoJxCls7NiOfUJly2oX2IJUKvVmOY4DvSRts_3_zCTesBES13iiJDN-nhnneYaQt8IZb5wXaSklT4VWIdVCy9TI4CvGVBZ6NuH6VC3PxZcLeRH5T12kVW7XxH6hrlqPe-Qz8PyFNIJpM6sjLeLHyeLj1XWKHaTwT2tsp3GX3AOvKLGNg56zcb8F69oIzgfuOzbnmZ2sz75_OOMcC8RMvFJfvP_fJXrHR035kzsOafGQPIiRJD0eTP-I3AnNY7K_jv_Kn5DlMiBb2lOk7G7a7rKjKyyNSFcd3RolVBQ3Yilmo5TRSI_p6HyXaP6UnC8-_5wv09g3IfXCMJPWzgPUWI2-2bmAGQ7knEKHouZBucCyEuKmUrlcuczkvjQh1IjMEmJYlrP8Gdlr2ia8ILTmufcsSMOrIAopXF4KXvuM1yHjTuQJebfVm70aymNYSCtQvxb1a6N-E_IJlTrKYFHr_kJ788tGjFiITb3XdRYgZBVCmlJoJ5B3lqmKl5on5AhNYocToiM07bHKdKHhKVlC3vcSCE6wjHfxjAF8DJa5mkgeTiQBVH46vDW7jaDu7N8pmJA34zDeiUS1JrS3vUwuCg1BUUKeD7Nk_GhYPvF0pkpIMZk_E61MR5rL333JbwVpJaSWB_9_rSOyD5iw31anX1-S-xDameHU5CHZ29zchlcQPm3K1z0u_gDJXRad |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+Steatosis+Index+Is+Associated+with+Type+1+Diabetes+Complications&rft.jtitle=Diabetes%2C+metabolic+syndrome+and+obesity&rft.au=Tripolino%2C+Cesare&rft.au=Irace%2C+Concetta&rft.au=Cutruzzola%2C+Antonio&rft.au=Parise%2C+Ma&rft.date=2019-11-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-7007&rft.eissn=1178-7007&rft.spage=2405&rft_id=info:doi/10.2147%2FDMSO.S221969&rft.externalDocID=A608789690 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7007&client=summon |